ERNA vs IONS · P/E 0.0, rev $582.0K vs rev $226.6M
Eterna Therapeutics Inc (ERNA) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ERNA and IONS stock pages for the full models.
Not investment advice.